| Date Filed | Type | Description |
| 01/05/2016 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Paid exercise price by delivering 14,412 options to buy
@ $73.77, valued at
$1.1M
|
|
| 11/09/2015 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Sold 147,054 shares
@ $74.67, valued at
$11M
Sold 800,345 shares
@ $76.66, valued at
$61.4M
Sold 350,000 shares
@ $84.26, valued at
$29.5M
|
|
| 03/02/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/09/2015 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 450,000 options to buy
@ $0 |
|
| 03/13/2014 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 502,996 options to buy
@ $0 |
|
| 12/17/2013 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Bought 184,247 shares
@ $81.41, valued at
$15M
|
|
| 12/19/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/26/2012 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Paid exercise price by delivering 25,787 shares
@ $0 |
|
| 04/26/2012 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Paid exercise price by delivering 101,877 shares
@ $0 |
|
| 04/16/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/28/2011 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Paid exercise price by delivering 50,997 shares
@ $0 |
|
| 10/26/2011 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 155,642 shares
@ $0 |
|
| 10/03/2011 |
4
| Pearson J. Michael (Chairman of the Board and CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 120,000 options to buy
@ $0
Granted 500,000 options to buy
@ $54.76, valued at
$27.4M
|
|
| 08/15/2011 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Bought 155,642 shares
@ $38.6192, valued at
$6M
|
|
| 04/26/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/14/2011 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Disposed/sold 929,364 shares
@ $39.5, valued at
$36.7M
|
|
| 10/20/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/06/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/30/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/29/2010 |
3
| Pearson J. Michael (CEO) has filed a Form 3 on Valeant Pharmaceuticals International, Inc. |
| 02/03/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/08/2009 |
4
| Pearson J. Michael (CEO and Chairman of the Board) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL|
Txns:
| Paid exercise price by delivering 188,875 shares
@ $31.93, valued at
$6M
|
|
| 12/03/2009 |
4
| Pearson J. Michael (CEO and Chairman of the Board) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL|
Txns:
| Granted 200,481 options to buy
@ $0
Granted 173,750 options to buy
@ $0
Granted 500,000 options to buy
@ $37.41, valued at
$18.7M
|
|
| 07/27/2009 |
4
| Pearson J. Michael (CEO and Chairman of the Board) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL |
| 05/08/2009 |
4
| Pearson J. Michael (CEO and Chairman of the Board) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL |